Dementia Alzheimer Type: Clinical Trials

2 trials for Dementia Alzheimer Type, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 2
Phase 22Recruiting 2

Follow Dementia Alzheimer Type: new trials by email Literature Review of Dementia Alzheimer Type trials Research Report on Dementia Alzheimer Type

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rifaximin SSD in Dementia Trial
Rifaximin SSD 40 mg IR tablet, Placebo - Dementia Alzheimer Type, Dementia Associated With Cerebrovascular Disease
Phase 1 / Phase 2RecruitingJasmohan Bajaj202024-12-302026-04-03
Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)
TMS, Transcranial Magnetic Stimulation Sham - Alzheimer&Amp;Amp;#39;s Disease, Alzheimer Disease
Phase 1 / Phase 2RecruitingUniversity of California, Los Angeles542024-10-172026-09-04

Narrower conditions

Alzheimer Disease (2)  ·  Dementia (1)  ·  Dementia, Vascular (1)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurocognitive Disorders (2)  ·  Neurodegenerative Diseases (2)  ·  Tauopathies (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Dementia (1)  ·  Intracranial Arterial Diseases (1)  ·  Intracranial Arteriosclerosis (1)  ·  Leukoencephalopathies (1)

Sponsors

Jasmohan Bajaj (1)  ·  University of California, Los Angeles (1)

Countries

United States (2)

Top investigators

Jasmohan Bajaj (1)  ·  Michael Leuchter, MD, MSc (1)

Results publications

PMID 40065917

NIH funding

K23AG097987 (1)